Screening of cognitive impairment in the old and old-old population with the 3-CT scale

Da, Gutorova; Васенина, Е. Е.; Os, Levin

doi:10.17116/jnevro20161166235-40

Cited by 13 publications

(1 citation statement)

References 23 publications

(31 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Вопросы критериальной валидности и рубежных показателей теста MoCA активно обсуждаются. Большинством работ, включая Клинические рекомендации «Когнитивные расстройства у пациентов пожилого и старческого возраста» [6], показатель 25 баллов и ниже трактуется как наличие когнитивного дефицита [21,22], рубежный показатель для оценки деменции определяется в диапазоне от 19 до 21 балла [21,23,24].…”

Section: обоснованиеunclassified

Early detection of the risk of cognitive disorders

Mashkova¹,

Dmitrieva²,

Krikova³

et al. 2023

Medical Journal of the Russian Federation

View full text Add to dashboard Cite

BACKGROUND: The problem of cognitive disorders is relevant in an aging population. The research results show a wide range of data on the prevalence of cognitive disorders in the general population. It is necessary to further study the prevalence of various cognitive disorders and assess the risks of their development. This will determine the burden on the healthcare system in the regions. AIMS: to study the possibilities of early detection of the risk of cognitive disorders among outpatient patients of the polyclinic. MATERIALS AND METHODS: Screening in a population of people aged 45 to 90 years using the Montreal Cognitive Assessment Scale. RESULTS: The proportion of people with cognitive dysfunction is: 20.0% in the age group 45-59 years, 33.1% in the age group 60-74 years, 79.6% in the age group 75-90 years. The average value according to the results of the assessment of cognitive functions in persons aged 45-59 years (27.1 0.3) and aged 60-74 years (26.2 0.2) corresponds to the norm, and in persons aged 75-90 years (23.6 0.3) is below the norm. In the age groups of 60-74 and 75-90 years, the same prevalence of cognitive dysfunction between men and women. Cognitive impairments in the group of 45-59-year-olds in men are recorded 2.5 times more often than in women. The risk of cognitive disorders in the second group (age 60-74 years) relative to the first group (age 45-59 years) is insignificant (Relative risk (RR) is 1.21). In the third group (age 75-90 years), the probability of cognitive disorders is significantly higher than in the second (RR = 2.40) and almost five times higher than in the first group (RR = 4.86). CONCLUSIONS: Gender- and age-stratified screening indicators for assessing cognitive functions and the relative risks of developing cognitive disorders in older age groups make it possible to plan diagnostic, therapeutic and preventive measures in the field of mental health.

show abstract

Section: обоснованиеunclassified